Mark Lawler

Chair, The Lancet Oncology Commission
  • The Lancet Oncology Commission
  • Contributors
  • United Kingdom

About Mark Lawler

Mark Lawler is Professor of Digital Health at Queen’s University Belfast and led the Lancet Oncology European Groundshot Commission. He is a member of the board of the European Cancer Organisation, Europe’s largest multi-professional cancer organisation) and co-chairs their Special Focussed Network on the Impact of COVID-19 on Cancer and is a member of the Scientific Committee of the European Cancer Patient Coalition (Europe’s largest cancer patient advocacy organisation).

Stakeholder Group

Academia NGO/Civil Society

Intro Content

COVID-19 Recovery Health Innovation

Follow the Science, Follow the Data: Averting a European cancer crisis

The COVID-19 pandemic, the war in Ukraine and the cost-of-living crisis have unravelled our progress on cancer survival, but we also have a significant opportunity. The ambitious but achievable goal? An average of 70% ten-year survival rates for all European patients with cancer by 2035. Banner: Shutterstock/Rapeepat Pornsipak

Influencer Of